BENJAMIN HO: Open Payments
NPI 1982015939 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 22 payments from 13 companies in 2025. Trend: 2023 $487 · 2024 $766 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $135 |
| AstraZeneca Pharmaceuticals LP | 5 | $133 |
| ABBVIE INC. | 1 | $120 |
| Novo Nordisk Inc | 2 | $51 |
| Exact Sciences Corporation | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Amgen Inc. | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, AIRSUPRA, Ozempic, Cologuard Collection Kit, Qelbree, KRYSTEXXA, INSPIRE.
Industry payments across GA — which companies pay providers there.
